Menu
Amblyopia (Lazy-eye) affects 3% of all population and puts the patients at risk for eventual vision loss.
Gold Standard treatment for lazy eye is placing a patch over the strong eye – an old-fashioned solution which suffers from very low compliance.
With the CureSight™ binocular treatment, children develop stereoscopic vision, which is difficult to be achieved with the monocular nature of the traditional patching treatment.
Amblyopia (Lazy-eye) affects 3% of all population and puts the patients at risk for eventual vision loss. Gold Standard treatment for lazy eye is placing a patch over the strong eye – an old-fashioned solution which suffers from very low compliance With the CureSight™ binocular treatment, children develop stereoscopic vision, which is difficult to be achieved with the monocular nature of the traditional patching treatment.
Multicenter, randomized, controlled pivotal study of CureSight against the gold standard patching
Parents that are likely or very likely to choose the CureSight over patching
As objectively measured by CureSight’s eye tracking system
© 2022 NovaSight | All Rights Reserved | NS-00779-R05
Disclaimer: Caution – EyeSwift® and CureSight™ are investigational devices, limited by Federal (Or United States) law to investigational use
Your data will be handled in accordance with our Privacy
Policy. In the event that a child’s or minor’s information is
being submitted as part of this form, we hereby request
that such information be submitted solely by the legal
guardian of such child or minor.
Your data will be handled in accordance with our Privacy
Policy. In the event that a child’s or minor’s information is
being submitted as part of this form, we hereby request
that such information be submitted solely by the legal
guardian of such child or minor.
This website uses cookies for functional, operational, analytical and advertising purposes. Please review our Privacy Policy for more information
